SO
AVIR icon

STRS Ohio’s Atea Pharmaceuticals AVIR Stock Holding History

STRS Ohio’s Portfolio AVIR Stock Details AVIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$519K Sell
96,400
-17,100
-15% -$78.5K ﹤0.01% 1066
2025
Q4 		$405K Hold
113,500
– – ﹤0.01% 1180
2025
Q3 		$329K Hold
113,500
– – ﹤0.01% 1292
2025
Q2 		$409K Buy
113,500
+8,000
+8% +$23.9K ﹤0.01% 1399
2025
Q1 		$315K Hold
105,500
– – ﹤0.01% 1384
2024
Q4 		$353K Hold
105,500
– – ﹤0.01% 1326
2024
Q3 		$353K Hold
105,500
– – ﹤0.01% 1399
2024
Q2 		$349K Buy
105,500
+10,800
+11% +$40.3K ﹤0.01% 1388
2024
Q1 		$382K Sell
94,700
-6,000
-6% -$23.5K ﹤0.01% 1362
2023
Q4 		$307K Hold
100,700
– – ﹤0.01% 1451
2023
Q3 		$302K Hold
100,700
– – ﹤0.01% 1452
2023
Q2 		$376K Buy
100,700
+5,500
+6% +$20.6K ﹤0.01% 1393
2023
Q1 		$318K Sell
95,200
-32,700
-26% -$133K ﹤0.01% 1485
2022
Q4 		$615K Buy
127,900
+36,800
+40% +$186K ﹤0.01% 1197
2022
Q3 		$518K Sell
91,100
-3,900
-4% -$29.9K ﹤0.01% 1317
2022
Q2 		$674K Sell
95,000
-28,700
-23% -$196K ﹤0.01% 1166
2022
Q1 		$893K Buy
123,700
+25,700
+26% +$175K ﹤0.01% 1106
2021
Q4 		$876K Buy
98,000
+60,200
+159% +$938K ﹤0.01% 1196
2021
Q3 		$1.32M Buy
37,800
+700
+2% +$19.4K 0.01% 938
2021
Q2 		$796K Buy
37,100
+28,900
+352% +$868K ﹤0.01% 1341
2021
Q1 		$506K Buy
8,200
+4,700
+134% +$318K ﹤0.01% 1566
2020
Q4 		$146K Buy
+3,500
New +$113K ﹤0.01% 1812

Other funds holding AVIR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

STRS Ohio's AVIR Position: Q1 2026 in Review

STRS Ohio reduced its Atea Pharmaceuticals (AVIR) stake by 15% in Q1 2026, selling an estimated $78.5K and leaving 96,400 shares worth $519K. The position accounts for ﹤0.01% of the portfolio, ranked #1066.

STRS Ohio first reported a position in AVIR in Q4 2020 and has held it in 22 quarters since. The position peaked at $1.32M in Q3 2021. 127 funds tracked by Wall St. Rank hold AVIR as of Q1 2026.

  • STRS Ohio held 96,400 shares of Atea Pharmaceuticals worth $519K as of Q1 2026.
  • STRS Ohio sold 17,100 Atea Pharmaceuticals shares in Q1 2026, an estimated $78.5K.
  • Atea Pharmaceuticals made up ﹤0.01% of STRS Ohio's portfolio in Q1 2026, its #1066 holding.
  • STRS Ohio first reported a position in Atea Pharmaceuticals in Q4 2020 and has held it in 22 quarters since.
  • STRS Ohio's Atea Pharmaceuticals position peaked at $1.32M in Q3 2021.
  • 127 funds tracked by Wall St. Rank held Atea Pharmaceuticals as of Q1 2026.

Based on STRS Ohio's 13F filing for Q1 2026, filed 24 Apr 2026.